Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

MRI Shows Brain Atrophy in Type 2 Diabetes Patients

Posted: Wednesday, September 30, 2009

Patients with Type 2 diabetes have more pronounced brain atrophy and are more likely to have cerebral infarcts, a new published study suggests.

Dr. Jane S. Saczynski, of the University of Massachusetts Medical School, Worcester, and colleagues examined the association of glycemic status and magnetic resonance imaging (MRI) findings of brain pathological changes in 4,415 elderly residents of Iceland (mean age, 76 years) without dementia participating in the Age Gene/Environment Susceptibility-Reykjavik Study.

Overall, 2,327 (53%) were normoglycemic, 1,599 (36%) had impaired fasting glucose, and 489 (11%) had Type 2 diabetes.

After adjustment for demographic and cardiovascular risk factors, Type 2 diabetic patients had significantly lower total brain volume (71.5% vs. 72.2%), gray matter volume (44.9% vs. 45.1%), and white matter volume (25.3% vs. 25.7%) compared to normoglycemic subjects.

Patients with Type 2 diabetes were also more likely to have single (odds ratio 1.45) or multiple (OR 2.27) cerebral infarcts, compared to normoglycemic individuals.

Longer duration of diabetes was associated with lower percentage of total brain volume, lower percentage of gray and white matter, and higher percentage of white matter lesions, as well as with a significantly greater likelihood of having single or multiple cerebral infarcts.

In secondary analyses, use of diabetes medication and hemoglobin A1c levels were examined in relation to brain tissue volumes and the presence of cerebral infarcts. Just more than half -- 56% -- of diabetic subjects were taking either hypoglycemic medications or insulin.

Compared with diabetics who were not taking medication, patients on medication had a significantly lower percentage of total brain volume (adjusted mean percentage 70.9 vs. 72.4) and lower percentages of gray matter (44.5 vs. 45.4) and white matter (24.9 vs. 25.6) volume, according to the report.

The authors found no association between quartiles of A1c and brain tissue volumes or the presence of infarcts.

"These findings are based on cross-sectional data and should be replicated in longitudinal studies," the research team points out.

Source: Diabetes In Control: Diabetes Care Sept, 2009;32:1608-1613.

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement